Prognostic significance and pathogenesis of RFC3 gene expression in diffuse large B-cell lymphoma

RFC3 may serve as a novel prognostic biomarker and a potential therapeutic target for DLBCL. Further investigations into the mechanisms underlying RFC3 dysregulation may provide important insights for future diagnostic and therapeutic strategies.

Authors

Institutions

Publication Details

Journal
PeerJ
Published
2025-09-16
DOI
https://doi.org/10.7717/peerj.20001
Primary Topic
Lymphoma Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Prognostic significance and pathogenesis of RFC3 gene expression in diffuse large B-cell lymphoma

Shui-Yu Liu, Zuguo Tian, Chunlan Weng
PeerJ
Lymphoma Diagnosis and Treatment
article

Prognostic significance and pathogenesis of RFC3 gene expression in diffuse large B-cell lymphoma

Shui-Yu Liu, Zuguo Tian, Chunlan Weng
article en

Abstract

RFC3 may serve as a novel prognostic biomarker and a potential therapeutic target for DLBCL. Further investigations into the mechanisms underlying RFC3 dysregulation may provide important insights for future diagnostic and therapeutic strategies.

PeerJVol. 13
Zunyi Medical University (CN)
Openalex Percentile: Top 65%
Lymphoma Diagnosis and Treatment
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Prognostic significance and pathogenesis of RFC3 gene expression in diffuse large B-cell lymphoma — Shui-Yu Liu, Zuguo Tian, et al. · PeerJ (2025) | TGRS Research Map | TGRS